Johnson & Johnson’s big consumer-healthcare business priced its initial public offering at $22 a share in the biggest new-stock listing of the year. The offering was priced at the higher end of the $20 to $23 targeted range, with about 10% more shares sold than planned, according to people familiar with the matter. At that price, the offering is expected to raise at least $3.7 billion and value the new company, known as Kenvue, at more than $40 billion.
Read the full article: J&J Prices Consumer Unit IPO at $22 a Share //
Source: https://www.wsj.com/articles/j-j-prices-consumer-unit-ipo-at-22-a-share-1950af12